Answers are grounded in this paper and cite their sources.
Observational analysis highlights barriers in gene therapy financing, suggesting multi-stakeholder trust may enhance practices.
Widespread uptake of ICs will require a multi-stakeholder collaboration to overcome common barriers, as a one-size-fits-all approach is insufficient for diverse stakeholder needs. Establishing industry-wide contracting principles and practices may help bridge differences in opinions and build trust between contracting parties, allow stakeholders to share lessons from early adopters, and support efficient contracting processes that promote consistent and equitable patient access to GTs while ensuring healthcare system sustainability.
No takes yet. Share an insight, caveat, or question.
Gould et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: